DK2977457T3 - Idna-vacciner og fremgansmåder til anvendelse af disse - Google Patents
Idna-vacciner og fremgansmåder til anvendelse af disse Download PDFInfo
- Publication number
- DK2977457T3 DK2977457T3 DK15166439.8T DK15166439T DK2977457T3 DK 2977457 T3 DK2977457 T3 DK 2977457T3 DK 15166439 T DK15166439 T DK 15166439T DK 2977457 T3 DK2977457 T3 DK 2977457T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- idna
- vaccines
- idna vaccines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/193—Equine encephalomyelitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24161—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
- C12N2770/36161—Methods of inactivation or attenuation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8148208P | 2008-07-17 | 2008-07-17 | |
| EP09798313.4A EP2310510B1 (en) | 2008-07-17 | 2009-07-17 | Idna vaccines and methods for using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2977457T3 true DK2977457T3 (da) | 2021-12-06 |
Family
ID=41550920
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09798313.4T DK2310510T3 (da) | 2008-07-17 | 2009-07-17 | IDNA-vacciner og fremgangsmåder til deres anvendelse |
| DK15166439.8T DK2977457T3 (da) | 2008-07-17 | 2009-07-17 | Idna-vacciner og fremgansmåder til anvendelse af disse |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09798313.4T DK2310510T3 (da) | 2008-07-17 | 2009-07-17 | IDNA-vacciner og fremgangsmåder til deres anvendelse |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US8691563B2 (da) |
| EP (3) | EP3992296A1 (da) |
| BR (1) | BRPI0916186B8 (da) |
| DK (2) | DK2310510T3 (da) |
| ES (2) | ES2544702T3 (da) |
| HK (1) | HK1220720A1 (da) |
| WO (1) | WO2010008576A2 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2544702T3 (es) * | 2008-07-17 | 2015-09-02 | Medigen, Inc. | Vacunas en forma de ADNi y métodos para utilizarlas |
| US10602508B2 (en) * | 2015-08-10 | 2020-03-24 | Qualcomm Incorporated | LTE-direct communication for vehicle-to-vehicle |
| WO2018208856A1 (en) | 2017-05-08 | 2018-11-15 | Gritstone Oncology, Inc. | Alphavirus neoantigen vectors |
| KR20200118029A (ko) | 2018-01-04 | 2020-10-14 | 아이코닉 테라퓨틱스, 인코포레이티드 | 항-조직 인자 항체, 항체-약물 결합체, 및 관련 방법 |
| TW202110870A (zh) | 2019-05-30 | 2021-03-16 | 美商葛利史東腫瘤科技公司 | 經修飾之腺病毒 |
| CN116438308A (zh) | 2020-08-06 | 2023-07-14 | 磨石生物公司 | 多表位疫苗盒 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI9701774B8 (pt) * | 1997-04-11 | 2015-09-29 | Fundação Oswaldo Cruz Fiocruz | cdna mutante e infeccioso do vírus da febre amarela, constructo de dna, vírus recombinante de febre amarela e vacina para humanos contra infecções de febre amarela. |
| BR9909173A (pt) * | 1998-03-27 | 2000-12-05 | Secr Defence | ácido nucleico, mutante de deleção de um alfa-vìrus, adenovìrus recombinante, vìrus vacìnia recombinante, plasmìdeo, vacina, e, processo para produzir uma imune resposta protetora a um alfa-vìrus |
| FR2779736B1 (fr) | 1998-06-12 | 2002-12-13 | Goemar Lab Sa | Genes codant pour des beta-agarases et leur utilisation pour la production d'enzymes de biodegradation des agars |
| AU771774B2 (en) * | 1998-12-07 | 2004-04-01 | U.S. Medical Research Institute Of Infectious Diseases | Live attenuated Venezuelan equine encephalitis vaccine |
| GB2372991B (en) * | 2001-03-09 | 2004-11-17 | Fiocruz Fundacao Oswaldo Cruz | Flavivirus expression vector |
| EP2305299B1 (en) * | 2001-05-31 | 2017-03-01 | GlaxoSmithKline Biologicals SA | Chimeric alphavirus replicon particles |
| AU2003902842A0 (en) | 2003-06-06 | 2003-06-26 | The University Of Queensland | Flavivirus replicon packaging system |
| WO2005026316A2 (en) * | 2003-09-15 | 2005-03-24 | Bioption Ab | Alphavirus vaccines |
| US7459163B2 (en) * | 2004-02-25 | 2008-12-02 | University Of Kansas | Infectious DNA as a vaccine against west nile and other flaviviruses |
| US20060198854A1 (en) | 2004-12-28 | 2006-09-07 | Peter Pushko | Vector platforms derived from the alphavirus vaccines |
| ES2544702T3 (es) * | 2008-07-17 | 2015-09-02 | Medigen, Inc. | Vacunas en forma de ADNi y métodos para utilizarlas |
| PT2519266T (pt) * | 2009-12-31 | 2017-11-10 | Medigen Inc | Vacinas de dna infeccioso contra o vírus chikungunya |
-
2009
- 2009-07-17 ES ES09798313.4T patent/ES2544702T3/es active Active
- 2009-07-17 DK DK09798313.4T patent/DK2310510T3/da active
- 2009-07-17 BR BRPI0916186A patent/BRPI0916186B8/pt active IP Right Grant
- 2009-07-17 EP EP21192928.6A patent/EP3992296A1/en active Pending
- 2009-07-17 EP EP15166439.8A patent/EP2977457B1/en active Active
- 2009-07-17 WO PCT/US2009/004133 patent/WO2010008576A2/en active Application Filing
- 2009-07-17 ES ES15166439T patent/ES2902787T3/es active Active
- 2009-07-17 EP EP09798313.4A patent/EP2310510B1/en active Active
- 2009-07-17 DK DK15166439.8T patent/DK2977457T3/da active
- 2009-07-17 US US13/054,372 patent/US8691563B2/en active Active - Reinstated
-
2014
- 2014-01-30 US US14/168,788 patent/US9968672B2/en active Active
-
2016
- 2016-07-20 HK HK16108634.7A patent/HK1220720A1/zh unknown
-
2018
- 2018-04-19 US US15/957,550 patent/US10653769B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0916186B8 (pt) | 2021-05-25 |
| EP2977457A2 (en) | 2016-01-27 |
| US10653769B2 (en) | 2020-05-19 |
| WO2010008576A3 (en) | 2010-04-29 |
| EP2977457B1 (en) | 2021-09-01 |
| BRPI0916186B1 (pt) | 2021-03-09 |
| US20110243989A1 (en) | 2011-10-06 |
| US20180243404A1 (en) | 2018-08-30 |
| US20140178430A1 (en) | 2014-06-26 |
| EP3992296A1 (en) | 2022-05-04 |
| ES2902787T3 (es) | 2022-03-29 |
| US9968672B2 (en) | 2018-05-15 |
| EP2310510A2 (en) | 2011-04-20 |
| HK1220720A1 (zh) | 2017-05-12 |
| BRPI0916186A2 (pt) | 2018-05-29 |
| EP2310510B1 (en) | 2015-05-06 |
| WO2010008576A2 (en) | 2010-01-21 |
| EP2977457A3 (en) | 2016-05-04 |
| US8691563B2 (en) | 2014-04-08 |
| ES2544702T3 (es) | 2015-09-02 |
| EP2310510A4 (en) | 2012-01-25 |
| DK2310510T3 (da) | 2015-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3702371T3 (da) | Anti-FGFR3-antistoffer og fremgangsmåder ved anvendelse af disse | |
| DK3266367T3 (da) | Systemer og fremgangsmåder til billeddannelse ved anvendelse af absorption | |
| DK2337568T3 (da) | Fremgangsmåder og midler til blødvævsteknologi | |
| DK2223731T3 (da) | Indretning til genindvinding af CO2 og fremgangsmåde til genindvinding af CO2 | |
| DK2152748T3 (da) | Anti-Notch1-NRR-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK2255293T3 (da) | Indretninger og fremgangsmåder til evaluering af en person til et søvnsystem | |
| DK2270818T3 (da) | Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten | |
| DK2331238T3 (da) | Fremgangsmåde og enhed til fotosyntesestøttet co2-bortskaffelse | |
| DK2147315T3 (da) | Diabetesrelaterede biomarkører og fremgangsmåder til anvendelse deraf | |
| DK2327066T3 (da) | Anordning og fremgangsmåde til at detektere anvendelse af en trådløs anordning under kørsel | |
| DK3000943T3 (da) | Forbindelsesindretning til fastgørelse af ekspanderede cellebegrænsningsstrukturer og fremgangsmåder til anvendelse deraf | |
| DK3862529T3 (da) | Fremgangsmåde og apparat til anvendelse ved nedlæggelse af borebrønde | |
| DK3375470T3 (da) | Apparat og fremgangsmåde til pumpning af fluid | |
| DK2133134T3 (da) | Anordning og fremgangsmåde til behandling af udstødningsgas | |
| DK2376519T3 (da) | TGR5-modulatorer og fremgangsmåde til anvendelse deraf | |
| BRPI0807225A2 (pt) | Dispositivo e método endocirúrgico | |
| DK2518655T3 (da) | Anordning og fremgangsmåde til forebyggelse af hypoglykæmi | |
| BRPI0912934A2 (pt) | aparelho e método | |
| DK2229800T3 (da) | Fremgangsmåde og apparat til frigørelse af ressourcer | |
| BRPI0816907A2 (pt) | Método e dispositivo | |
| BRPI0910713A2 (pt) | método e aparelhos | |
| DK2346765T3 (da) | Indretning og fremgangsmåde til samling af flade genstande | |
| DK2131939T3 (da) | Filteranordning og fremgangsmåde | |
| DK2222314T3 (da) | Anvendelser og midler til opnåelse af bronchorelaxation | |
| DK2456544T3 (da) | Fremgangsmåde til fjernelse af gasformig væske og indretning dertil |